Ghent University Academic Bibliography

Advanced

Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10

Nathalie Huyghebaert, A VERMEIRE, S NEIRYNCK, Lothar Steidler UGent, Erik Remaut and Jean Paul Remon UGent (2005) EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 60(3). p.349-359
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Eur. J. Pharm. Biopharm.
volume
60
issue
3
pages
349-359 pages
publisher
Elsevier Science
Web of Science type
Article
Web of Science id
000230781800004
JCR category
PHARMACOLOGY & PHARMACY
JCR impact factor
2.525 (2005)
JCR rank
60/191 (2005)
JCR quartile
2 (2005)
ISSN
0939-6411
DOI
10.1016/j.ejpb.2005.02.012
language
English
UGent publication?
yes
classification
A1
id
320679
handle
http://hdl.handle.net/1854/LU-320679
date created
2005-08-19 14:57:00
date last changed
2016-12-19 15:44:34
@article{320679,
  author       = {Huyghebaert, Nathalie and VERMEIRE, A and NEIRYNCK, S and Steidler, Lothar and Remaut, Erik and Remon, Jean Paul},
  issn         = {0939-6411},
  journal      = {EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS},
  language     = {eng},
  number       = {3},
  pages        = {349--359},
  publisher    = {Elsevier Science},
  title        = {Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10},
  url          = {http://dx.doi.org/10.1016/j.ejpb.2005.02.012},
  volume       = {60},
  year         = {2005},
}

Chicago
Huyghebaert, Nathalie, A VERMEIRE, S NEIRYNCK, Lothar Steidler, Erik Remaut, and Jean Paul Remon. 2005. “Development of an Enteric-coated Formulation Containing Freeze-dried, Viable Recombinant Lactococcus Lactis for the Ileal Mucosal Delivery of Human Interleukin-10.” European Journal of Pharmaceutics and Biopharmaceutics 60 (3): 349–359.
APA
Huyghebaert, Nathalie, VERMEIRE, A., NEIRYNCK, S., Steidler, L., Remaut, E., & Remon, J. P. (2005). Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 60(3), 349–359.
Vancouver
1.
Huyghebaert N, VERMEIRE A, NEIRYNCK S, Steidler L, Remaut E, Remon JP. Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. Elsevier Science; 2005;60(3):349–59.
MLA
Huyghebaert, Nathalie, A VERMEIRE, S NEIRYNCK, et al. “Development of an Enteric-coated Formulation Containing Freeze-dried, Viable Recombinant Lactococcus Lactis for the Ileal Mucosal Delivery of Human Interleukin-10.” EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS 60.3 (2005): 349–359. Print.